• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Soleno Therapeutics, Inc. - Common Stock (NQ:SLNO)

    62.74 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 8, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 812
    Open 62.74
    Bid (Size) 62.30 (1)
    Ask (Size) 63.99 (1)
    Prev. Close 62.74
    Today's Range 62.74 - 62.74
    52wk Range 41.50 - 90.32
    Shares Outstanding 8,168,788
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    10 Health Care Stocks Whale Activity In Today's Session
     
    Via Benzinga
    SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire

    Performance

    YTD
    +37.3%
    +37.3%
    1 Month
    -13.2%
    -13.2%
    3 Month
    -29.1%
    -29.1%
    6 Month
    -0.8%
    -0.8%
    1 Year
    +20.7%
    +20.7%

    More News

    Read More
    SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    SOLENO INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
    From Pomerantz LLP
    Via GlobeNewswire
    Acadia Pharma Faces Trial Setback As Prader-Willi Syndrome Trial Falls Short
    Via Benzinga
    Acadia Pharma Tumbles On Failed Appetite Suppressant; Soleno Surges
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
    From Pomerantz LLP
    Via GlobeNewswire
    SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Soleno Therapeutics, Inc. (SLNO) Under Investigation After Scorpion Capital Report Raises Drug Safety Concerns; Investors Urged to Contact Award-Winning Firm, Gibbs Mura
    From Gibbs Mura
    Via Business Wire
    SLNO Investors Have Opportunity to Join Soleno Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Soleno Therapeutics Stock Tanks After Patient Treated With Drug Dies – More Details Inside
    Via Stocktwits
    Topics Death
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
    From Pomerantz LLP
    Via GlobeNewswire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
    From Pomerantz LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating Fortinet, Roblox, Soleno, and Simulations Plus and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO
    From Pomerantz LLP
    Via GlobeNewswire
    SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating Soleno Therapeutics, Inc. on Behalf of Soleno Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO
    From The Rosen Law Firm, P.A.
    Via Business Wire

    Frequently Asked Questions

    Is Soleno Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Soleno Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Soleno Therapeutics, Inc. - Common Stock trade on?
    Soleno Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Soleno Therapeutics, Inc. - Common Stock?
    The ticker symbol for Soleno Therapeutics, Inc. - Common Stock is SLNO on the Nasdaq Stock Market
    What is the current price of Soleno Therapeutics, Inc. - Common Stock?
    The current price of Soleno Therapeutics, Inc. - Common Stock is 62.74
    When was Soleno Therapeutics, Inc. - Common Stock last traded?
    The last trade of Soleno Therapeutics, Inc. - Common Stock was at 10/08/25 04:00 PM ET
    What is the market capitalization of Soleno Therapeutics, Inc. - Common Stock?
    The market capitalization of Soleno Therapeutics, Inc. - Common Stock is 512.51M
    How many shares of Soleno Therapeutics, Inc. - Common Stock are outstanding?
    Soleno Therapeutics, Inc. - Common Stock has 513M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.